| Title |
Topiramate for the prophylaxis of episodic migraine in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2013
|
| DOI | 10.1002/14651858.cd010610 |
| Pubmed ID | |
| Authors |
Mattias Linde, Wim M Mulleners, Edward P Chronicle, Douglas C McCrory |
| Abstract |
Some antiepileptic drugs but not others are useful in clinical practice for the prophylaxis of migraine. This might be explained by the variety of actions of these drugs in the central nervous system. The present review is part of an update of a Cochrane review first published in 2004, and previously updated (conclusions not changed) in 2007. |
X Demographics
The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 9 | 36% |
| United States | 4 | 16% |
| United Kingdom | 2 | 8% |
| Grenada | 1 | 4% |
| Dominican Republic | 1 | 4% |
| Mexico | 1 | 4% |
| New Zealand | 1 | 4% |
| Unknown | 6 | 24% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 18 | 72% |
| Scientists | 4 | 16% |
| Practitioners (doctors, other healthcare professionals) | 2 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 375 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | <1% |
| Denmark | 2 | <1% |
| Netherlands | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 369 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 57 | 15% |
| Student > Bachelor | 48 | 13% |
| Student > Ph. D. Student | 25 | 7% |
| Researcher | 24 | 6% |
| Student > Doctoral Student | 23 | 6% |
| Other | 56 | 15% |
| Unknown | 142 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 138 | 37% |
| Nursing and Health Professions | 23 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 3% |
| Psychology | 10 | 3% |
| Agricultural and Biological Sciences | 8 | 2% |
| Other | 34 | 9% |
| Unknown | 149 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2023.
All research outputs
#1,396,540
of 25,460,914 outputs
Outputs from Cochrane database of systematic reviews
#2,974
of 12,090 outputs
Outputs of similar age
#11,631
of 209,375 outputs
Outputs of similar age from Cochrane database of systematic reviews
#64
of 297 outputs
Altmetric has tracked 25,460,914 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,375 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 297 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.